Co-Chair Daniel Einhorn, MD, FACP, FACE, talks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL about the early results of SGLT2 inhibitors and the cardiovascular benefits and cardiac outcomes.
In this video, Sara Horst, MD, MPH, from Vanderbilt University Medical Center, discusses how she manages opportunistic infections among patients with IBD.
Scott Kahan, MD, MPH, director of the National Center for Weight and Wellness in Washington, DC, gives helpful strategies for counseling patients with obesity.
Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.